Milestone Advisory Partners’s Bio-Techne TECH Stock Holding History

Milestone Advisory Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,420	Closed	-$243K	–	78
2022 Q3	$243K	Hold	3,420	–	–	0.18%	59
2022 Q2	$302K	Hold	3,420	–	–	0.24%	49
2022 Q1	$370K	Hold	3,420	–	–	0.2%	56
2021 Q4	$442K	Hold	3,420	–	–	0.22%	51
2021 Q3	$414K	Hold	3,420	–	–	0.24%	48
2021 Q2	$385K	Hold	3,420	–	–	0.2%	50
2021 Q1	$327K	Buy	+3,420	New	+$312K	0.18%	47

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Milestone Advisory Partners's TECH Position: Q4 2022 in Review

Milestone Advisory Partners sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 3,420 shares — an estimated $243K sold.

Milestone Advisory Partners first reported a position in TECH in Q1 2021 and held it in 7 quarters. The position peaked at $442K in Q4 2021. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

Milestone Advisory Partners reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
Milestone Advisory Partners sold 3,420 Bio-Techne shares in Q4 2022, an estimated $243K.
Milestone Advisory Partners first reported a position in Bio-Techne in Q1 2021 and held it in 7 quarters.
Milestone Advisory Partners's Bio-Techne position peaked at $442K in Q4 2021.
545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Milestone Advisory Partners's 13F filing for Q4 2022, filed 24 Jan 2023.